Change search
ReferencesLink to record
Permanent link

Direct link
Liver Transplantation for Transthyretin Amyloidosis
Head Division of Transplantation Surgery, CLINTEC, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Umeå University, Faculty of Medicine, Department of Molecular Biology (Faculty of Medicine).
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Medicine.
2009 (English)In: Recent Advances in Transthyretin Evolution, Structure and Biological Functions / [ed] Dr. Samantha J. Richardson, Dr. Vivian Cody, New York: Springer Berlin/Heidelberg, 2009, 239-260 p.Chapter in book (Other academic)
Abstract [en]

Liver transplantation has until now proved to be the only treatment available that halts the progression of hereditary transthyretin (TTR) associated amyloidosis. The rationale behind the procedure is to replace the liver producing variant TTR with one that produces wild type TTR only, and thereby cease the production of amyloidogenic TTR (ATTR). Even though the transplantation does not improve the patient's symptoms, the progression of the disease comes to a halt for a majority of patients. However, unforeseen complications after the transplantation have emerged, in particular a continuous amyloid formation in the heart observed in non-ATTR Val30Met mutations. Thus, combined liver and heart transplantation has been performed in selected cases. Since the ATTR liver functions normally apart from a synthesis of the variant TTR, utilisation of ATTR-amyloid patients' livers for transplantation of liver disease patients has been performed. In a few patients, development of amyloid disease has been reported, but the procedure remains an important source of organs, especially for patients with hepatocellular cancer.

Place, publisher, year, edition, pages
New York: Springer Berlin/Heidelberg, 2009. 239-260 p.
Keyword [en]
Transthyretin, Liver transplantation, Heart complication, Amyloidosis
National Category
Endocrinology and Diabetes
URN: urn:nbn:se:umu:diva-76163DOI: 10.1007/978-3-642-00646-3_15ISI: 000272520300016ISBN: 978-3-642-00645-6 (Print)ISBN: 978-3-642-00646-3 (Online)OAI: diva2:635735
Available from: 2013-07-05 Created: 2013-07-04 Last updated: 2013-07-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Lundgren, ErikSuhr, Ole B.
By organisation
Department of Molecular Biology (Faculty of Medicine)Medicine
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 59 hits
ReferencesLink to record
Permanent link

Direct link